Resultados clínicos do mel de Manuka em pacientes queimados: uma revisão de escopo

Introduction: Burns constitutes a public health problem with a high socioeconomic impact worldwide. Historically, honey has been used to treat wounds. Manuka honey stands out for its high methylglyoxalcontent, which gives it superior therapeutic potential. However, clinical evidence on its effectiveness in burns is heterogeneous and lacks a synthesis that evaluates clinical outcomes. Objective: to synthesize the available evidence on the composition of dressings with Manuka honey and their outcomes in the care of burn patients in hospital settings. Methods: Scope review was conducted according to PRISMA-ScR guidelines. The PCC (Population, Content, Context) strategy was employed. The population of interest consisted of burn patients. Treatments with Manuka honey and their outcomes, such as healing,infection, pain, exudate, patient satisfaction, costs, and others, were analyzed. Finally, the study context focused on inpatient settings. Results: Five articles were included: three case series, one uncontrolled clinical trial, and one retrospective cohort study. The findings show that Manuka honey accelerates epithelialization, reduces bacterial load (including multidrug-resistant strains), promotes pain management, and is cost-effective. Conclusion: Available clinical evidence suggests that Manuka honey has positive effects on wound healing, bacterial control, and pain. However, the findings are not conclusive due to the study's limitations. Therefore, more rigorous clinical trials are needed tovalidate these findings.